Brazil's National Health Surveillance Agency (Anvisa) has requested some additional information from Wyeth/Pfizer regarding booster doses of their COVID-19 vaccine for children and adolescents and is still waiting for a reply, Agencia Brasil reported Friday.
Brazilian health authorities Thursday launched a campaign explaining the proper use and handling of the Janssen COVID-19 vaccine and the number of booster doses recommended for this specific drug.
The Pan American Health Organization (PAHO) has sent a letter of support to Uruguay's Health Minister Daniel Salinas after a judge ordered all vaccination of children under 13 years of age against COVID-19 be halted in the country.
A group of Uruguayan anti-vaccine protesters gathered Wednesday at the courthouse doorstep in support of Surrogate Judge Alejandro Recarey's decision earlier this week to request information from the Health Ministry (MSP) and the Pfizer laboratory regarding anti-COVID-19 vaccines.
An Uruguayan court has ruled that the national government and the laboratory Pfizer must disclose during a hearing this coming Wednesday the exact components of the COVID-19 vaccine of that brand which is widely used throughout the country.
According to a study released Tuesday by Brazil's Oswaldo Cruz Foundation (Fiocruz), patients who have taken the two-shot scheme of CoronaVac's drug would be better off if they receive a booster injection of the Pfizer vaccine.
Pharmaceutical giant Pfizer has announced it planned to submit a COVID-19 vaccine for children under the age of 5 to the Food and Drug Administration (FDA) of the United for emergency authorization. If approved, it would be the first such drug available in the United States for that age group.
Brazil's National Health Surveillance Agency (Anvisa) Friday released a statement warning of the differences between COVID-19 vaccines for children to highlight the specifics of newly-released drugs.
The European Medicines Agency (EMA) Thursday announced it had approved the use of Pfizer's anti-COVID-19 pill Paxlovid, which has thus become the first oral treatment cleared for use in the European Union. The new drug is a combination of the molecule PF-07321332 and the HIV antiviral Ritonavir.
Uruguay Tuesday became the fifth country to join the European Union's covid-19 certificate program. It is also South America's first.